SOURCE: Industrial Info Resources
October 19, 2012 06:15 ET
SUGAR LAND, TX--(Marketwire - Oct 19, 2012) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- With but a scant three months left of 2012, the Pharmaceutical-Biotech Industry is on track to an impressive finish in North America. The sector is set to launch a whopping $3 billion of capital construction and maintenance projects during the fourth quarter. That money is targeted for investment in 257 projects, delivering an average total investment value of $12 million per project.
Other companies featured: Johnson & Johnson (NYSE:JNJ), Regeneron (NASDAQ:REGN)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showAbstract.jsp?newsitemID=230225&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.
See all RSS Newsfeeds